BRIEF—Dyve Biosciences launches as dermal delivery technology company

Dyve Biosciences officially launched today as a new face in the biopharmaceutical space in Thousand Oaks, California.

The core beliefs of the organization reflect the realization by the leadership team, after many years in traditional corporate environments, that there is a better way to do business; better for patients, better for physicians, and better for their own employees.

Central to the company is Dyve Technology, an innovative approach that enables therapy to be transported fast and deep through the skin, allowing rapid penetration into targeted tissue.

This unique approach offers the promise of delivering therapeutic molecules to areas that could previously only be reached with a needle.